As Daubers noted in the recent filing, IPIX has other means to finance ops -- below... #2 the preferred imo. Advance the pipeline via partnerships.
Dilutive financing the name-of-game in biotech but hoping we're about to enter a new phase. Less need for Aspire via Deal/s.
--
The Company may consider other plans to fund operations including: (1) raising additional capital through debt financings or from other sources; (2) additional funding through new relationships to help fund future clinical trial costs (i.e. licensing and partnerships); (3) reducing spending on one or more research and development programs by discontinuing development; and/or (4) restructuring operations to change its overhead structure.